Bayesian Capital Management LP Acquires New Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Bayesian Capital Management LP purchased a new stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 12,400 shares of the company’s stock, valued at approximately $631,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Brown Advisory Inc. boosted its holdings in shares of Establishment Labs by 63.9% during the 4th quarter. Brown Advisory Inc. now owns 2,428,792 shares of the company’s stock valued at $62,881,000 after acquiring an additional 946,612 shares during the last quarter. Capital Research Global Investors bought a new stake in Establishment Labs during the 1st quarter worth approximately $45,888,000. Fourth Sail Capital LP bought a new stake in shares of Establishment Labs during the fourth quarter valued at approximately $14,473,000. Bamco Inc. NY raised its position in shares of Establishment Labs by 28.4% during the first quarter. Bamco Inc. NY now owns 429,775 shares of the company’s stock valued at $21,876,000 after buying an additional 95,000 shares during the last quarter. Finally, William Blair Investment Management LLC bought a new stake in shares of Establishment Labs during the first quarter valued at approximately $21,415,000. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Insiders Place Their Bets

In other Establishment Labs news, CEO Quiros Juan Jose Chacon sold 6,839 shares of the company’s stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $45.30, for a total value of $309,806.70. Following the sale, the chief executive officer now owns 218,896 shares in the company, valued at approximately $9,915,988.80. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In the last 90 days, insiders have sold 14,346 shares of company stock worth $647,806. Corporate insiders own 11.44% of the company’s stock.

Establishment Labs Stock Down 3.5 %

Shares of ESTA stock traded down $1.67 during trading hours on Tuesday, reaching $45.39. 186,408 shares of the company’s stock were exchanged, compared to its average volume of 371,255. Establishment Labs Holdings Inc. has a 1 year low of $16.96 and a 1 year high of $73.00. The stock has a market cap of $1.25 billion, a PE ratio of -14.48 and a beta of 1.24. The company has a current ratio of 4.24, a quick ratio of 2.73 and a debt-to-equity ratio of 3.38. The stock’s fifty day moving average price is $47.23 and its two-hundred day moving average price is $46.50.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.58) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.65) by $0.07. The business had revenue of $37.17 million for the quarter, compared to analyst estimates of $35.61 million. Establishment Labs had a negative return on equity of 206.05% and a negative net margin of 53.12%. The company’s revenue was down 20.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.48) earnings per share. Research analysts predict that Establishment Labs Holdings Inc. will post -1.79 EPS for the current year.

Analyst Upgrades and Downgrades

ESTA has been the subject of a number of recent research reports. Citigroup cut their target price on shares of Establishment Labs from $60.00 to $50.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. Mizuho lifted their price objective on shares of Establishment Labs from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, June 6th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $54.00.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.